EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Late Clinical Outcomes of Balloon-Expandable Valves in Small Annuli

Rebecca T Hahn, Philippe Pibarot, Amr Abbas, Raj Makkar, Vinod H Thourani, Philippe Généreux, Susheel Kodali, Samir Kapadia, Vasilis Babaliaros, Julien Ternacle, Alexis Theron, Nicole Cristell und 9 weitere

JACC: Cardiovascular Interventions · 2025

DOI: 10.1016/j.jcin.2024.11.006 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025. Verfasst von Rebecca T Hahn und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA; Clinical Trials Center, Cardiovascular Research Foundatio…. Hauptthemen laut MEDLINE: Aortic Valve, Aortic Valve Stenosis, Balloon Valvuloplasty, Heart Valve Prosthesis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Edwards Lifesciences Corp.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Short-term clinical outcomes after transcatheter aortic valve replacement (TAVR) are similar in individuals with small or large annuli. The longer term impact of prosthesis-patient mismatch (PPM) and mean gradient (MG) post-TAVR in these patients remains controversial. OBJECTIVES: The aim of this study was to investigate 5-year outcomes in patients with small vs large annuli. METHODS: Patients from the PARTNER (Placement of Aortic Transcatheter Valves) 2 SAPIEN 3 intermediate-risk registry and the PARTNER 3 low-risk randomized controlled trial were grouped according to small (≤430 mm2) or large (>430 mm2) annular size. The primary endpoint was a composite of all-cause death, disabling stroke, or heart failure hospitalization. In addition, the relationships between both PPM and post-TAVR MG and clinical outcomes were analyzed. RESULTS: In total, 1,355 patients were included: 476 with small annuli (376.7 ± 41.9 mm2) and 879 with large annuli (518.3 ± 58.0 mm2). Patients with small annuli were older (age 79.6 ± 7.1 years vs 78.7 ± 7.8 years; P = 0.047), were more often female (75.0% vs 16.2%; P < 0.0001), had higher baseline Society of Thoracic Surgeons scores (4.3% ± 1.93% vs 4.0% ± 1.93%; P < 0.0001), and had higher left ventricular ejection fractions (66.3% ± 15.82% vs 59.7% ± 13.68%; P < 0.0001). Primary endpoint rates were similar at 1 year (7.8% vs 8.0%; P = 0.94) and 5 years (36.3% vs 35.8%; P = 0.83). Bioprosthetic valve failure was infrequent at 5 years in both groups (2.9% vs 2.1%; P = 0.46). Among female patients, outcomes were similar for small vs large annuli (primary endpoint; 33.6% vs 34.2%; P = 0.90). Among patients with small annuli, there was no association between 5-year outcomes and any severity of PPM (P = 0.22) or 30-day MG (P for nonlinearity = 0.96). CONCLUSIONS: Five-year clinical outcomes were excellent and comparable between patients with small vs large aortic annuli. Outcomes in patients with small annuli were not affected by 30-day MG or PPM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic ValveAortic Valve StenosisBalloon ValvuloplastyHeart Valve ProsthesisTranscatheter Aortic Valve ReplacementAgedAged, 80 and overFemaleHumansMaleHeart FailureHemodynamicsProsthesis DesignRandomized Controlled Trials as TopicRecovery of FunctionRegistriesRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeProspective Studies

Stichwörter der Autor:innen

hemodynamic statussmall annulustranscatheter aortic valve

Autor:innen und Institutionen

  • Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA. Electronic address: rth2@columbia.edu.
  • Département de Cardiologie, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec City, Quebec, Canada.
  • Department of Cardiovascular Medicine, CHE-William Beaumont University Hospital, Royal Oak, Michigan, USA.
  • Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Department of Cardiovascular Surgery, Marcus Valve Center, Piedmont Heart Institute, Atlanta, Georgia, USA.
  • Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA.

Förderung

  • Edwards Lifesciences Corp

Zitieren

APA

Hahn, R. T., Pibarot, P., Abbas, A., Makkar, R., Thourani, V. H., Généreux, P., Kodali, S., Kapadia, S., Babaliaros, V., Ternacle, J., Theron, A., Cristell, N., Clarke, S., Zhao, Y., Alu, M., Madhavan, M. V., Cohen, D. J., Leipsic, J., Webb, J., …, & Leon, M. B. (2025). Late Clinical Outcomes of Balloon-Expandable Valves in Small Annuli. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2024.11.006

Vancouver

Hahn RT, Pibarot P, Abbas A, Makkar R, Thourani VH, Généreux P, et al. Late Clinical Outcomes of Balloon-Expandable Valves in Small Annuli. JACC: Cardiovascular Interventions. 2025. doi:10.1016/j.jcin.2024.11.006

BibTeX
@article{Hahn2025,
  author = {Hahn, Rebecca T and Pibarot, Philippe and Abbas, Amr and Makkar, Raj and Thourani, Vinod H and Généreux, Philippe and Kodali, Susheel and Kapadia, Samir and Babaliaros, Vasilis and Ternacle, Julien and Theron, Alexis and Cristell, Nicole and Clarke, Sarah and Zhao, Yanglu and Alu, Maria and Madhavan, Mahesh V and Cohen, David J and Leipsic, Jonathon and Webb, John and Mack, Michael J and Leon, Martin B},
  title = {Late Clinical Outcomes of Balloon-Expandable Valves in Small Annuli},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1016/j.jcin.2024.11.006}
}
Kostenlos starten →